Factors associated with establishing a causal diagnosis for children with cardiomyopathy

被引:86
作者
Cox, Gerald F.
Sleeper, Lynn A.
Lowe, April M.
Towbin, Jeffrey A.
Colan, Steven D.
Orav, E. John
Lurie, Paul R.
Messere, Jane E.
Wilkinson, James D.
Lipshultz, Steven E.
机构
[1] Univ Miami, Leonard M Miller Sch Med, Dept Pediat, Miami, FL 33101 USA
[2] Univ Miami, Batchelor Childrens Res Inst, Jackson Mem Ctr, Holtz Childrens Hosp, Miami, FL 33152 USA
[3] Univ Miami, Mailman Inst Child Dev, Miami, FL 33152 USA
[4] Childrens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA
[5] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[7] Harvard Univ, Sch Med, Dept Internal Med, Boston, MA 02115 USA
[8] Genzyme Corp, Clin Res, Cambridge, MA USA
[9] New England Res Inst, Watertown, MA USA
[10] Baylor Coll Med, Houston, TX 77030 USA
[11] Texas Childrens Hosp, Dept Pediat Cardiol, Houston, TX 77030 USA
[12] Texas Childrens Hosp, Dept Mol & Human Genet, Houston, TX 77030 USA
[13] Texas Childrens Hosp, Dept Cardiovasc Sci, Houston, TX 77030 USA
[14] Albany Med Coll, Dept Pediat, Albany, NY 12208 USA
[15] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA
关键词
idiopathic cardiomyopathy; hypertrophic cardiomyopathy; dilated cardiomyopathy; restrictive cardiomyopathy; myocarditis; inborn errors of metabolism; malformation syndrome; neuromuscular; endomyocardial biopsy;
D O I
10.1542/peds.2006-0163
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
OBJECTIVE. The goal was to identify the clinical variables associated with establishing a cause of cardiomyopathy in children. METHODS. The Pediatric Cardiomyopathy Registry contains clinical and causal testing information for 916 children who were diagnosed as having cardiomyopathy in North America between 1990 and 1995. Children with a causal diagnosis were compared with those without with respect to several demographic, clinical, and causal testing variables. RESULTS. Cardiomyopathy was 1 of 4 types, hypertrophic (34.2%), dilated (53.8%), restrictive (3.2%), or other or mixed (8.9%). Only one third of cases had a known cause. Children with a known cause for hypertrophic cardiomyopathy were more likely to be female, to be relatively smaller, to present with congestive heart failure, and to have increased left ventricular posterior wall thickness without outflow tract obstruction. For dilated cardiomyopathy, a known cause was associated with older age, lower heart rate, smaller left ventricular dimensions, and greater shortening fraction. Family history of cardiomyopathy predicted a significantly higher rate of causal diagnoses for all cardiomyopathy types, whereas family histories of genetic syndromes and sudden death were also predictive of a cause for hypertrophic and dilated cardiomyopathies. For hypertrophic cardiomyopathy, only blood and urine testing was associated with a causal diagnosis, whereas both viral serologic testing or culture and endomyocardial biopsy were independent predictors of a causal diagnosis in dilated cardiomyopathy. CONCLUSIONS. Certain patient characteristics, family history, echocardiographic findings, laboratory testing, and biopsy were associated significantly with establishing a cause of pediatric cardiomyopathy. Early endomyocardial biopsy should be considered strongly for children with dilated cardiomyopathy, for definitive diagnosis of viral myocarditis. Although not widely used, skeletal muscle biopsy may yield a cause for some patients with hypertrophic cardiomyopathy and for patients suspected of having a mitochondrial disorder.
引用
收藏
页码:1519 / 1531
页数:13
相关论文
共 31 条
[21]   Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction [J].
Pauschinger, M ;
Bowles, NE ;
Fuentes-Garcia, FJ ;
Pham, V ;
Kühl, U ;
Schwimmbeck, PL ;
Schutheiss, HP ;
Towbin, JA .
CIRCULATION, 1999, 99 (10) :1348-1354
[22]   Familial carnitine transporter defect: A treatable cause of cardiomyopathy in children [J].
Pierpont, MEM ;
Breningstall, GN ;
Stanley, CA ;
Singh, A .
AMERICAN HEART JOURNAL, 2000, 139 (02) :S96-S106
[23]   Hypertrophic cardiomyopathy - Distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy [J].
Richard, P ;
Charron, P ;
Carrier, L ;
Ledeuil, C ;
Cheav, T ;
Pichereau, C ;
Benaiche, A ;
Isnard, R ;
Dubourg, O ;
Burban, M ;
Gueffet, JP ;
Millaire, A ;
Desnos, M ;
Schwartz, K ;
Hainque, B ;
Komajda, M .
CIRCULATION, 2003, 107 (17) :2227-2232
[24]   Report of the 1995 World Health Organization International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies [J].
Richardson, P ;
McKenna, W ;
Bristow, M ;
Maisch, B ;
Mautner, B ;
OConnell, J ;
Olsen, E ;
Thiene, G ;
Goodwin, J ;
Gyarfas, I ;
Martin, I ;
Nordet, P .
CIRCULATION, 1996, 93 (05) :841-842
[25]   ENDOMYOCARDIAL BIOPSIES FOR EARLY DETECTION OF MITOCHONDRIAL DISORDERS IN HYPERTROPHIC CARDIOMYOPATHIES [J].
RUSTIN, P ;
LEBIDOIS, J ;
CHRETIEN, D ;
BOURGERON, T ;
PIECHAUD, JF ;
ROTIG, A ;
MUNNICH, A ;
SIDI, D .
JOURNAL OF PEDIATRICS, 1994, 124 (02) :224-228
[26]   Clinical approach to genetic cardiomyopathy in children [J].
Schwartz, ML ;
Cox, GF ;
Lin, AE ;
Korson, MS ;
PerezAtayde, A ;
Lacro, RV ;
Lipshultz, SE .
CIRCULATION, 1996, 94 (08) :2021-2038
[27]   Pediatric cardiomyopathy - A long way to go [J].
Strauss, A ;
Lock, JE .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1703-1705
[28]   Cardiomyopathies: is it time for a molecular classification? [J].
Thiene, G ;
Corrado, D ;
Basso, C .
EUROPEAN HEART JOURNAL, 2004, 25 (20) :1772-1775
[29]   Genetic abnormalities responsible for dilated cardiomyopathy [J].
Towbin J.A. ;
Bowles N.E. .
Current Cardiology Reports, 2000, 2 (5) :475-480
[30]   Pediatric myocardial disease [J].
Towbin, JA .
PEDIATRIC CLINICS OF NORTH AMERICA, 1999, 46 (02) :289-+